Cure My Disease

Don't miss your cure!

Home News About
Log in / Sign up
← Back to home

Chongqing Claruvis Pharmaceutical Co., Ltd.

Clinical trials sponsored by Chongqing Claruvis Pharmaceutical Co., Ltd., explained in plain language.

Trials to join now! 2
Sort by
  • New injection aims to loosen paralyzed arms in stroke survivors

    Disease control Recruiting now

    This study is testing a new formulation of botulinum toxin (called YY001) to see if it can safely reduce severe muscle stiffness in the arm of adults who have had a stroke. About 254 participants will receive injections to see how well the treatment relaxes their tight muscles an…

    Phase: PHASE2, PHASE3 • Sponsor: Chongqing Claruvis Pharmaceutical Co., Ltd. • Aim: Disease control

    Last updated Mar 30, 2026 14:33 UTC

  • New treatment tested to loosen paralyzed arms

    Disease control Recruiting now

    This study is testing the long-term safety and effectiveness of repeated injections of a new botulinum toxin (YY001) for adults with stiff, tight arm muscles (spasticity) after a stroke. It aims to see if multiple treatments over time can safely reduce muscle tightness and improv…

    Phase: PHASE3 • Sponsor: Chongqing Claruvis Pharmaceutical Co., Ltd. • Aim: Disease control

    Last updated Mar 25, 2026 14:07 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Terms of use Contact us

This is a site from Cyber and Space